Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2721069 | 1.00 | — | — | |
| SCHEMBL633945 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1367113 | 0.95 | — | — | |
| SCHEMBL2831574 | 0.95 | ALOX15 (0.48) | — | |
| O-Xylene SCHEMBL5239726 | 0.82 | TAAR1 (0.59) | — | |
| Hydrochloric Acid SCHEMBL20451409 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL1430250 | 0.81 | TERT (0.50) | — | |
| Trifluoroacetic Acid SCHEMBL30689202 | 0.80 | TBXAS1 (0.46) | — | |
| SCHEMBL366871 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL11095387 | 0.78 | TBXAS1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283145-A1 | METHODS FOR BASE-LEVEL DETECTION OF METHYLATION IN NUCLEIC ACIDS | Roche Sequencing Solutions, Inc. | 2025-09-11 | — | — | US | claimed |
| EP-4291677-A2 | METHODS FOR BASE-LEVEL DETECTION OF METHYLATION IN NUCLEIC ACIDS | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | claimed |
| CN-116806266-A | Method for detection of methylated base level in nucleic acids | 豪夫迈·罗氏有限公司 | 2023-09-26 | — | — | CN | claimed |
| WO-2022171606-A2 | METHODS FOR BASE-LEVEL DETECTION OF METHYLATION IN NUCLEIC ACIDS | F. HOFFMANN-LA ROCHE AG (CH) | 2022-08-18 | — | — | WO | claimed |
| US-20250376468-A1 | PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS | UNIV LEUVEN KATH (BE) | 2025-12-11 | — | — | US | disclosed |
| US-12472543-B2 | Waste disposal system and waste receiver for receiving and disposing of pharmaceutical waste material | STRYKER CORPORATION (US) | 2025-11-18 | — | — | US | disclosed |
| US-12434282-B2 | Pharmaceutical waste system | STRYKER CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250283145-A1 | METHODS FOR BASE-LEVEL DETECTION OF METHYLATION IN NUCLEIC ACIDS | Roche Sequencing Solutions, Inc. | 2025-09-11 | — | — | US | disclosed |
| US-20250268679-A1 | Waster Receiver For Receiving A Pharmaceutical Waste Material | STRYKER CORPORATION (US) | 2025-08-28 | — | — | US | disclosed |
| US-12318823-B2 | Waste receiver for receiving a pharmaceutical waste material | STRYKER CORPORATION (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250144680-A1 | Pharmaceutical Waste Disposal Assembly | STRYKER CORPORATION (US) | 2025-05-08 | — | — | US | disclosed |
| EP-3902638-B1 | METHOD OF DISPOSING OF WASTE RECEIVER AND WASTE RECEIVER FOR PHARMACEUTICAL WASTE | STRYKER CORP (US) | 2025-02-26 | — | — | EP | disclosed |
| EP-0526009-A1 | Inhibitors of hiv protease useful for the treatment of aids | ELI LILLY AND COMPANY (US) | 1993-02-03 | — | — | EP | disclosed |
| US-5066654-A | 2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants | A. H. ROBINS COMPANY, INCORPORATED (US) | 1991-11-19 | — | — | US | disclosed |
| US-4861879-A | VAGINAL FUNGICIDE | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-08-29 | — | — | US | disclosed |
| EP-0118138-B1 | ((4-(4-(4-PHENYL-1-PIPERAZINYL)PHENOXYMETHYL)-1,3-DIOXOLAN-2-YL)METHYL)-1H-IMIDAZOLES AND 1H-1,2,4-TRIAZOLES | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-06-14 | — | — | EP | disclosed |
| US-4812467-A | ANTIULCER AGENTS | SYNTHELABO (FR) | 1989-03-14 | — | — | US | disclosed |
| US-4735942-A | FUNGICIDE, BACTERICIDE PARTICULARLY FOR UROGENITAL DISORDERS | JANSSEN PHARMACEUTICA, N.V. (BE) | 1988-04-05 | — | — | US | disclosed |
| US-4619931-A | BACTERICIDES, FUNGICIDES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1986-10-28 | — | — | US | disclosed |
| EP-0118138-A1 | ((4-(4-(4-Phenyl-1-piperazinyl)phenoxymethyl)-1,3-dioxolan-2-yl)methyl)-1H-imidazoles and 1H-1,2,4-triazoles | JANSSEN PHARMACEUTICA N.V. (BE) | 1984-09-12 | — | — | EP | disclosed |